Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Gene expression differences in PFS patients suggest a potential organic cause for symptoms.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

Hair is important for social and sexual communication in humans.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Scientists discovered a unique hair protein, KAP24.1, with a special structure, found only in the upper part of hair cuticles.

The document discusses new insights into how hormones affect male sexual health and related conditions.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Progranulin overexpression leads to shorter, thinner hair and increased cell death in mouse hair follicles.